Drug intelligence / Profile preview

U73122

Development stage
Unknown
Modality
Small Molecules
Administration
In Vitro, Ex Vivo, Intraperitoneal, Intravenous
01

Overview

U73122 is a synthetic small-molecule aza-steroid widely used as a research tool compound and originally characterized as a selective inhibitor of phosphoinositide-specific phospholipase C (PLC), with reported IC50 values around 1–6 µM for PLC-β3 in cell-based systems.[1][2][3][13] It contains an electrophilic maleimide moiety on a 3‑methoxyestradiol core, enabling covalent reaction with cellular nucleophiles and leading to inhibition of PLC-dependent phosphatidylinositol 4,5-bisphosphate hydrolysis, subsequent inositol 1,4,5-trisphosphate and diacylglycerol generation, and downstream Ca2+ and protein kinase C signaling.[1][2][3][6][7][9][13] Subsequent work has shown that U73122 also inhibits phospholipase A2, the sarcoplasmic reticulum Ca2+ pump, and human 5‑lipoxygenase, and exerts diverse effects including antiplatelet activity, inhibition of neutrophil adhesion and degranulation, modulation of Ca2+ homeostasis, and antinociceptive actions, indicating that it is a relatively nonselective covalent modulator of multiple signaling pathways rather than a strictly specific PLC inhibitor.[1][3][4][5][7][9][13]

Other names
1-[6-[[(17β)-3-methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-1H-pyrrole-2,5-dione1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione1-[6-[[(8R,9S,13S,14S,17S)-3-methoxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]amino]hexyl]pyrrole-2,5-dione3-O-methyl-17β-estradiol 17-(6-maleimidylhexyl)amine derivative
02

Targets

ATP2A (Sarcoplasmic reticulum Ca2+-ATPase)PLC (Phospholipase C family)TRP (TRP channels)ALOX12 (Arachidonate 12-lipoxygenase, 12S type)

Beyond the preview

Go deeper on U73122.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on U73122.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call